Extracellular matrix and its therapeutic potential for cancer treatment
2021 · Signal Transduction and Targeted Therapy · 850 citations
https://doi.org/10.1038/s41392-021-00544-0
Y
Yiting Qiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
2.7K
Citations
23
h-index
30
i10-index
Yiting Qiao is an academic researcher from Shanxi University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Cancer Research and Treatments & Nanoparticle-Based Drug Delivery. The author has an h-index of 23, co-authored 43 publications.
ORCID: 0000-0002-7518-4233Papers by this author
worksStimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
2018 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 319 citations
https://doi.org/10.1002/wnan.1527
USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1
2021 · Cell Death and Disease · 73 citations
https://doi.org/10.1038/s41419-021-04356-6
Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment
2023 · Hepatology · 31 citations
https://doi.org/10.1097/hep.0000000000000320
Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma
2023 · Oncogenesis · 10 citations
https://doi.org/10.1038/s41389-023-00499-7
Integrative analysis of the transcriptome and metabolome reveals the importance of hepatokine FGF21 in liver aging
2023 · Genes & Diseases · 1 citations
https://doi.org/10.1016/j.gendis.2023.101161
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat